Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy

This publication has 25 references indexed in Scilit:

• Trends in the Risks and Benefits to Patients With Cancer Participating in Phase 1 Clinical Trials
  JAMA, 2004
• Phase I Trial Design for Solid Tumor Studies of Targeted, Non-Cytotoxic Agents: Theory and Practice
  JNCI Journal of the National Cancer Institute, 2004
• Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review
  The Lancet, 2004
• Patients' understanding of risk
  BMJ, 2003
• Therapeutic misconception and the appreciation of risks in clinical trials
  Social Science & Medicine, 2003
• Striking the right balance in colorectal cancer care--a qualitative study of rural and urban patients
  Family Practice, 2002
• Assessing the quality of life of patients in phase I and II anti-cancer drug trials: interviews versus questionnaires
  Social Science & Medicine, 2002
• Response rates, duration of response, and dose response effects in phase I studies of antineoplastics
  Investigational New Drugs, 1991
• Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.
  BMJ, 1990
• Patient motivation and informed consent in a phase I study of an anticancer agent
  European Journal of Cancer and Clinical Oncology, 1984